Alleviant ALLAY-HFrEF Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.
Also called NCT06812533
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 350 participants
- Sponsor
- Alleviant Medical, Inc.
- Registry
-
NCT06812533
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, Canada, Georgia, Greece, Israel, New Zealand, Poland, Serbia, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06812533. Randomized; double masking; primary purpose treatment. Start 2025-03-10 (actual); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Alleviant ALLAY-HFrEF Study
- Condition
- Heart Failure
- Intervention (Device)
- Alleviant ALV1 System
- Intervention (Other)
- Sham-Control
- Lead sponsor
- Alleviant Medical, Inc.
Record details
- Record id
cardio:ct-nct06812533- Content hash
8afa101451c7aa8b2c460f988e45122fdb2dbee0132c2b2db3d616ebc1d4a1fd